Purpose. Motivated by increasing reports of antifungal resistance in human and animal sporotrichosis, this study evaluated the chemical composition, cytotoxicity and anti-Sporothrix brasiliensis activity of extracts of marjoram (Origanum majorana) and rosemary (Rosmarinus officinalis).
INTRODUCTION
Marjoram (Origanum majorana L.) and rosemary (Rosmarinus officinalis L.) are herbs from the Lamiaceae family that are widely used in the food and cosmetic industries for the flavouring properties of their essential oils [1, 2] . In popular medicine, infusions and decoctions of both plants have been used for their biological potential, including use for antiinflammatory, stimulant, hepatoprotective, healing and antimicrobial purposes, and to soothe respiratory signs and address rheumatic pain and blood disorders [1, 3, 4] .
Marjoram and rosemary extracts have shown antimicrobial properties against relevant human and veterinary pathogens, including in sporotrichosis, a zoonotic mycosis with worldwide distribution [2, [5] [6] [7] [8] . Sporotrichosis is transmitted through cutaneous inoculation of fungi from the Sporothrix schenckii complex by contact with contaminated plant material or zoonotic transmission by sick animals, mainly cats [9] . In Brazil, Sporothrix brasiliensis is considered to be the most virulent and prevalent species in feline sporotrichosis outbreaks [10, 11] . The resistance of the species to the available antifungal agents [7, 11, 12] has encouraged the search for new natural products with antifungal potential.
Although the essential oils of rosemary and marjoram have shown in vitro activity against Sporothrix schenckii complex [6] [7] [8] , there is no evidence concerning the effects of polar extracts of these species against Sporothrix spp.
Aqueous and hydroalcoholic extracts (HAEs) are known to possess therapeutic properties, primarily due to their phenolic and flavonoid composition [13, 14] . This study evaluated the anti-Sporothrix brasiliensis activity of rosemary (Rosmarinus officinalis) and marjoram (Origanum majorana) extracts and analysed their phenolic composition and cytotoxicity.
METHODS

Plant material
Dried aerial parts of Origanum majorana L. and Rosmarinus officinalis L. were purchased from Luar Sul -Indústria e Com ercio de Produtos Alimentícios Ltda (Santa Cruz do Sul, RS, Brazil).
Preparation of the plant extracts
Four extracts were prepared for each plant. Ten grammes of each herb were infused in 100 ml of boiling distilled water in an Erlermeyer and left at room temperature for either 10 min (INF10) or 60 min (INF60) and then filtered through filter paper to retain any solid particles. The decoction (DEC) was prepared by submerging 10 g of each herb in 100 ml of distilled water and then heating this until boiling was reached, before maintaining it at boiling temperature for 10 min and subsequently filtering it through filter paper to retain any solid particles. The HAE was prepared by extracting 100 g of each herb in 1 litre of alcohol (70 %) for 168 h under stirring. The extract was then filtered through sterile gauze and concentrated under reduced pressure using a rotatory evaporator. The residue was resuspended in distilled water.
Determination of total phenolic content Total phenolic content was determined by the FolinCiocalteu method [15] . Fifteen µL of the extract was mixed with 240 µl of distilled water and 15 µl of Folin-Ciocalteu solution (0.25 N). The mixture was homogenized and allowed to react for 10 min. Then, 30 µl of sodium carbonate (1 N) was added, homogenized and kept for 2 h. Absorbance was measured in a microplate reader (Spectra Max 190, Molecular Devices) at 725 nm. Total phenolic content was calculated based on a calibration curve using gallic acid as standard and the results were expressed in mg gallic acid g À1 of extract. Analyses were performed in triplicate.
Determination of total flavonoid content First, 30 µl of extracts were mixed with 120 µl of water and 9 µl of sodium nitrite (5 %) in the wells of a microplate and allowed to react for 5 min [16] . Then, 9 µl of aluminium chloride (10 %) was added. After 6 min, 60 µl of sodium hydroxide (1M) and 72 µl of distilled water were added. Absorbance was measured in a microplate reader (Spectra Max 190, Molecular Devices) at 510 nm and the results were expressed in mg epicatechin g À1 of extract. Analyses were performed in triplicate.
LC/UV/MS identification and quantification of phenolic compounds in plant extracts
Samples were filtered through a 0.22 µm nylon membrane filter (Millipore). The liquid chromatography/mass spectrometry (LC-MS) analysis was performed on a Prominence UFLC system (Shimadzu) coupled to a ultraviolet -UV-DAD detector and a mass spectrometry Bruker MicrOTOF Impact HD (Bruker Daltonics) detector. Phenolic compounds were separated using a Luna C18 reversed-phase silica 100 Å column (2.0Â150 mm, 100 Å, particle size 3 µm; Phenomonex). The solvents were 0.1 % aqueous formic acid (pH 2. . The injection volume was 10 µl, and the UV detection was performed between 200 nm and 600 nm. The parameters for MS analysis were set using the negative ion mode with spectra acquired over a mass range from m/z 50 to 1200. The parameters were: capillary voltage, +4.0 kV; drying-gas temperature, 180 C; drying-gas flow, 8.0 l min
À1
; nebulizing gas pressure, 2 bar; collision RF, 150 Vpp; transfer time, 70 µs, and pre-pulse storage, 5 µs. Moreover, automatic MS/MS experiments were performed, adjusting the collision energy values as follows -m z À1 100, 15 eV; m z À1 500, 35 eV; m z À1 1000, 50 eV -and using nitrogen as the collision gas. The MS data were processed through Data Analysis 4.0 software (Bruker Daltonics), which provided a list of possible elemental formulas by using the Smart Formula editor. Compounds were characterized by their ultraviolet/visible (UV/Vis) spectra (220-800 nm), retention times relative to external standards, mass spectra and MSn fragmentation patterns compared to data from databases (Metlin, MassBank and KeggCompound) and the reference literature. External calibration curves with caffeic acid, syringic acid, p-coumaric acid, ferulic acid, luteolin, rutin, chlorogenic acid, quercetin, hesperetin and 4-hydroxybenzoic acid standards (78 to 5000 ng ml À1 ) were prepared.
Cytotoxicity assay
Potential cytotoxic effects were determined using the colorimetric MTT [3-(4,5-dimethylthiazol-2-yl)À2,5-diphenyltetrazolium bromide] assay [17] in Crandell-Rees feline kidney (CRFK) and Madin-Darby canine kidney (MDCK) cell lines grown in Eagle's minimum essential medium (E-MEM; Sigma-Aldrich). Penicillin (Sigma-Aldrich), streptomycin (Vetec), enrofloxacin (Bayer) and amphotericin B (Crist alia) were supplemented with E-MEM at pH 7.2 in a humid atmosphere of 5 % CO 2 at 37 C. Trypsin was added onto the cell monolayer and cells were resuspended in E-MEM, resulting in a suspension with approximately 2Â10 5 cells ml
À1
. Aliquots of this cell suspension were placed in the individual wells of microplates, except for the first well, which served as a blank. Cells were incubated in E-MEM medium supplemented with 10 % foetal bovine serum (SFB, Gibco) at CO 2 5 % and 37 C for 24 h. Subsequently, 100 µl of the extracts in 10 successive dilutions on a logarithmic scale were added to the microplates. Concentrations of 0.078 to 40 mg ml À1 diluted in E-MEM were tested in triplicate for 48 h at 37 C in a humidified atmosphere of 5 % CO 2 . E-MEM alone was used as the control. Then, 50 µl MTT solution (1 mg ml À1 ) was added to each well and incubated for 4 h at 37 C and 5 % CO 2 . After removal of the MTT solution, 100 µl of dimethylsulfoxide (DMSO) was added to each well to dissolve the formazan crystals. The spectrophotometric absorbance of the samples was measured using a microplate reader at 540 nm. Cells were monitored by an inverted microscope and the mean of cell viability (%) was expressed in comparison with the respective control cells.
Anti-Sporothrix spp. activity For in vitro tests, 29 S. brasiliensis clinical isolates obtained from cats (n=12) and dogs (n=17) from southern Brazil with sporotrichosis were used, as well as a standard strain from human sporotrichosis caused by S. brasiliensis (IPEC 16919) and S. schenckii sensu stricto (IOC 1226), totalling 31 fungal isolates. All isolates were molecularly identified in the Laboratório de Micologia M edica Molecular (Federal University of São Paulo, Brazil) by PCR restriction fragment length polymorphism analysis [18] . The in vitro antifungal test was performed using the broth microdilution method, according to the CLSI M38-A2 standard protocol [19] . Fungal inocula were prepared from colonies grown in the mycelial phase at 27 C for 7 days. Saline solution (2 ml) with Tween 80 (1 %) was added to the surface of each colony and the fungal content was scraped with a scalpel blade in order to collect filament cells and conidia. The fungal content was transferred and suspended in tubes containing sterile saline, and then adjusted to 1.0 McFarland scale. Subsequently it was placed in a UV/Vis spectrophotometer (Spectrum Instruments Co.) with the transmittance adjusted to 80-82 % at a fixed wavelength of 530 nm. Suspensions were diluted in RPMI-1640 medium buffered with 2 % glucose and MOPS [3-(N-morpholino propanesulfonic acid)] at 1 : 50, v v À1 (Sigma). To obtain a concentration of 0.07 to 40 mg ml À1 , serial dilutions of the extracts were prepared using RPMI-1640 medium buffered with MOPS. Fungal suspension (100 µl) was added in all of the tested wells, including the positive control. Extract suspensions diluted in RPMI-1640 were used as a negative control. The positive control consisted of itraconazole for veterinary use (Cepav Pharma Ltda), which was diluted using DMSO. Microplates were incubated at 27 C for 72 h to obtain the results for minimum inhibitory concentration (MIC). For minimum fungicidal concentration (MFC), 10 µl aliquots of the wells with no fungal growth were transferred to Petri dishes containing Sabouraud dextrose agar (Acumedia) and incubated at 27 C for 72 h to visualize fungal growth. All experiments were performed in duplicate.
Statistical analysis
Analysis of variance and comparison of geometric means were performed using the Kruskal-Wallis test followed by Dunn's multiple-comparison test for antifungal assays and Fisher's least significant difference (LSD) test for cytotoxic analysis. Data were analysed using the statistical software BioEstat (version 5.3), and P-values of 0.05 and 0.01, respectively, were considered significant.
RESULTS
Total phenolic content was higher than total flavonoid content in all samples. The decreasing order of phenolic and flavonoid content in marjoram was DEC>INF10>-HAE>INF60. In rosemary, the order of total phenolic content was DEC>INF60>HAE>INF10, and that for total phenolic content was INF60>DEC>HAE>INF10. 4-hydroxybenzoic acid (4HBA) was the predominant phenolic acid found in all extracts of both plants. Hydroalcoholic extraction yielded the highest 4HBA content from marjoram (386.47±0.26 µg g À1 ) and rosemary (144.58±0.61 µg g À1 ). Caffeic and chlorogenic acids were also present in high amounts in all extracts of both plants. Flavonoids, however, were present in much lower concentrations. Luteolin was the predominant flavonoid in the HAE of rosemary, whereas hesperetin predominated in all the other extracts. In marjoram, luteolin was also high for all extracts, but was not detected in the 60 min infusion ( Table 1 ). The chromatograms for (and the chemical structures detected in) the HAEs of rosemary and marjoram are presented in Fig. 1 , together with the respective molecular masses and retention times.
The extract concentration was inversely proportional to cell viability, and the results were similar between cell lines (Table 2 ). In marjoram, concentrations up to 2.5 mg ml À1 (INF10, DEC, HAE) and 1.25 mg ml À1 (INF60) maintained the cell viability of the CRFK line, and for the MDCK line, the values were up to 10 mg ml À1 (INF10, DEC), 2.5 mg ml À1 (INF60) and 1.25 mg ml À1 (HAE). In rosemary, cell viability was observed in extract concentrations of up to 5 mg ml À1 (INF10, DEC) and 2.5 mg ml À1 (INF60, HAE) for the CRFK line, and up to 5 mg ml À1 (INF10), 2.5 mg ml À1 (INF60, DEC) and 0.625 mg ml À1 (HAE) for the MDCK line.
The anti-Sporothrix brasiliensis activity of the extracts of the aromatic herbs is shown in Table 3 . In rosemary, only one isolate from a feline (8.3 % -01/12) and seven isolates from canines (41.2 % -07/17) were sensitive to the MICs of extracts ranging from 0.313 to 40 mg ml À1 . The human standard strain was only sensitive to the HAE of rosemary (MIC 40 mg ml
À1
). There was no statistical difference between the MIC values of the rosemary extracts. Only the HAE of rosemary had fungicidal activity between the MFCs of 5 to 20 mg ml À1 against 20 % (06/30) of S. brasiliensis isolates.
In marjoram, only three feline (25 % -03/12) and seven canine (41.2 % -07/17) isolates of S. brasiliensis were sensitive to aqueous extracts at MICs of 0.625 to 40 mg ml
, but the standard strain was only sensitive to marjoram decoction (MIC 2.5 mg ml In S. schenckii sensu stricto, none of the rosemary extracts were active (MIC/MFC >40 mg ml À1 ). Among the infusions of marjoram, only INF60 was active (MIC 5 mg ml À1 ), and S. schenckii sensu stricto was strongly sensitive to decoction (MIC 0.31 mg ml À1 and MFC 2.5 mg ml
) and HAE 0.31 mg ml À1 and MFC 1.25 mg ml
) of marjoram, which showed fungistatic and fungicidal activity.
More than 60 % of clinical isolates of cats and dogs were sensitive to itraconazole, as well as S. schenckii sensu stricto (MIC 0.125 µg ml À1 ), according to the breakpoint suggested by the M38-A2 document [19] , which established the sensitivity of fungal isolates to itraconazole in MICs lower than 4 µg ml
, and resistance to the highest concentrations (Table 4) . However, 33.3 % (10/30) of all S. brasiliensis isolates were considered to be itraconazole-resistant. All itraconazole-resistant isolates from cats (04/12) were only sensitive to the HAE of marjoram (MIC of 20 to 40 mg ml ). The HAE of marjoram was active in all itraconazole-resistant isolates of Sporothrix brasiliensis and its mechanism should be studied, because its activity seems to open up an alternative route for the development of a new antifungal.
DISCUSSION
The identified phenolic and flavonoid profiles were similar to previously reported profiles for the aqueous and hydroalcoholic extracts of rosemary [20, 21] and marjoram [20, 22] . In rosemary, the INF10 extract had significantly lower total phenolic and flavonoid content than the INF60, while the opposite occurred for marjoram, which had lower content in the INF60 extract compared to the INF10. The longer extraction period seemed to have favoured the extractability of compounds in rosemary, but not in marjoram. In marjoram, the longer extraction at elevated temperature might have degraded some of the compounds.
Factors such as plant age, climate and soil type, and stress conditions that inhibit or encourage the production of certain compounds might affect the chemical composition -as might the geographical region of origin [23, 24] . These factors influence the metabolites qualitatively and quantitatively, which explains why certain compounds (quercetin, rutin, p-coumaric acid and luteolin) were not quantified in other studies [20, 25] . Carnosic acid, rosmarinic acid, ursolic acid, carnosol and rosmanol are compounds that were previously found in polar extracts of rosemary and marjoram [20, 21, 25, 26] , and although these compounds were not detected in the current study, their presence below detection limits should not be ruled out.
For the first time, the anti-Sporothrix brasiliensis activity of infusions, decoctions and HAEs from rosemary and marjoram was studied. Although the HAE of rosemary provokes morphological alterations in Trichophyton rubrum and T. mentagrophytes dermatophytes, through inhibition of mycelial growth and irregular formation of their hyphaes [27] , this activity was only weakly shown in S. brasiliensis, as well as in the remaining extracts of this plant. The modest fungistatic activity of the extracts may have been due to the concentrations of the polar compounds, because the essential oils of the plants were active [7] and their compositions were different from the extracts.
However, the HAE of marjoram stood out for its antifungal activity, and the high quantification of 4-HBA and luteolin seemed to be important. As a hypothetical mechanism of growth inhibition, 4-HBA alters the compartments of the fungal cells, such as in mitochondria [28] . Although the mechanism of action is not yet clear, luteolin may also be important in antifungal activity [29] [30] [31] , because it was also one of the predominant compounds, albeit only in the HAE of marjoram. The presence of caffeic acid and its derivatives has also been associated with antifungal activity [32] , because it causes morphological alterations, with loss of potassium in the fungal cell membrane, causing death [33] . Further, the associative presence of other compounds may show a synergistic effect. New studies with the chemical compounds should be undertaken in order to understand their mechanism of action, and also with the yeast phase of Sporothrix spp., in order to evaluate the activity of these extracts in these structures. The discovery of new products for sporotrichosis treatment is required, because itraconazole-resistant isolates of S. brasiliensis have been reported [8, 11, 12] .
Regarding in vitro toxicity, concentrations equal to or lower than 5 mg ml À1 were considered safe for CRFK and MDCK cell lines. El-Ashmawy et al. [3] also observed the safe use of aqueous and ethanolic extracts of marjoram, including with hepatoprotective activity. Silva et al. [34] observed antiinflammatory activity of the aqueous extract of rosemary at concentrations up to 400 mg kg
À1
. In our study, the HAE of marjoram show promising applicability for the pharmaceutical industry, because of its antifungal potential, which should be further studied.
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